Mangaluru: K MC Manipal lifts Medi Quiz 2019 trophy

Media Release
October 5, 2019

Mangaluru Oct. 05: K.M.C Manipal Duo team comprising of  Sudeep and   Sufyan Ibrahim emerged as winners  by securing  140 points and clinched the glittering Medi Quiz – 2019 Trophy.  The competition witnessed a very exciting close finish as they faced a stiff competition from the rival Fr. Muller Medical College Team comprising of  Sandeep Rao and Adhip Acharya who were Runner up by securing 120 points and had to settle for the Second Place.

The  Dept. of General Medicine A.J. Institute of Medical Sciences conducted their 8th Annual Dist. level Inter Medical Collegiate Quiz Contest  “Mediquiz – 2019” exclusively for the M.B.B.S under graduate Students on Friday at their conference hall.  The Quiz was exclusively on Medical subjects.

College Principal Prof. (Dr.) Ashok Hegde graced the occasion as Chief Guest and awarded the glittering Trophy, attractive prizes and Merit Certificates to the winners and Runners up and congratulated them on their exemplary achievements.  College Former Principal Dr. Ramesh Pai, Senior Professor Dr. Prabhakar Rao and Chief of the Dept. of Medicine Dr. E.V.S Maben were the guests of honour.  Dr. Devdas Rai was the Quiz Master.

The contest drew participants from 9 Medical Colleges (K.M.C., A.J.I.M.S., KSHEMA, Srinivasa, Fr.Muller, Yenepoya, K.M.C. Manipal. K.V.G. Sullia, Kanachur Medical College Deralakatte)

Dr. Adithi Santhosh Welcomed and Dr. Misba and Dr. Rupanjan officiated as Score Markers Dr. Anushree proposed a vote of thanks.  Bangalore based company M/s. Karnataka Antibiotics  Pharmaceutical Company sponsored this event.

Comments

Dr.Shafeeq
 - 
Saturday, 5 Oct 2019

Congratulations.

 

 
Nice to see 2 of our great teachers..Dr Ramesh Pai & Dr Prabhakar Rao. I wish them good health.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 24,2020

Kalaburagi, Feb 24: Former Karnataka chief minister Siddaramaiah on Monday alleged that dissatisfaction and unhappiness are rising among the local Bharatiya Janata Party MLAs and the party might soon witness large scale defection.

Addressing the media, Mr. Siddaramaiah said many of the BJP MLAs have openly expressed their disappointment and unhappiness with the BJPs high command and also with Chief Minister B S Yeddyurappa's attitude towards them and they have said that they want to join the Congress at the earliest.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 27,2020

Udupi, Jun 27: The Indian Meteorological Department and the Karnataka State Natural Disaster Monitoring Centre have sounded Orange alert in coastal Karnataka as there is all possibility of heavy rain lashing the region for the next three days from Saturday.

According to the forecast, the district may get 100 mm to 115 mm rainfall. The District Disaster Management Authority (DDMA) has given instructions on taking precautions in the district.

All officers of district and taluk-levels have been told to compulsorily remain in the central position. The citizens should take care not to venture into rivers or the sea. They should also stay away from electricity poles, buildings, and trees, which might prove dangerous, and take shelter in safer places.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.